HighTower Advisors
TECH icon

HighTower Advisors’s Bio-Techne TECH Stock Holding History

HighTower Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,277
Closed -$310K – 3936
2025
Q4 		$310K Buy
5,277
+138
+3% +$8.38K ﹤0.01% 3019
2025
Q3 		$286K Sell
5,139
-1,197
-19% -$64.1K ﹤0.01% 3086
2025
Q2 		$326K Sell
6,336
-3,482
-35% -$175K ﹤0.01% 2857
2025
Q1 		$576K Sell
9,818
-1,683
-15% -$114K ﹤0.01% 2343
2024
Q4 		$828K Sell
11,501
-940
-8% -$69K ﹤0.01% 2099
2024
Q3 		$995K Sell
12,441
-2,182
-15% -$164K ﹤0.01% 1933
2024
Q2 		$1.05M Sell
14,623
-3,566
-20% -$262K ﹤0.01% 1825
2024
Q1 		$1.29M Buy
18,189
+451
+3% +$32.3K ﹤0.01% 1659
2023
Q4 		$1.35M Sell
17,738
-1,128
-6% -$74.3K ﹤0.01% 1678
2023
Q3 		$1.29M Buy
18,866
+965
+5% +$76.2K ﹤0.01% 1622
2023
Q2 		$1.47M Buy
17,901
+809
+5% +$65K ﹤0.01% 1531
2023
Q1 		$1.25M Sell
17,092
-105
-0.6% -$8.09K ﹤0.01% 1548
2022
Q4 		$1.43M Buy
17,197
+625
+4% +$49.6K ﹤0.01% 1471
2022
Q3 		$1.18M Sell
16,572
-576
-3% -$49.8K ﹤0.01% 1520
2022
Q2 		$1.47M Sell
17,148
-232
-1% -$21.7K ﹤0.01% 1422
2022
Q1 		$1.88M Sell
17,380
-920
-5% -$94.9K ﹤0.01% 1413
2021
Q4 		$2.39M Buy
18,300
+600
+3% +$73.6K 0.01% 1260
2021
Q3 		$2.12M Buy
17,700
+316
+2% +$38.5K 0.01% 1224
2021
Q2 		$1.97M Buy
17,384
+1,296
+8% +$136K 0.01% 1230
2021
Q1 		$1.54M Buy
16,088
+924
+6% +$84.3K ﹤0.01% 1293
2020
Q4 		$1.2M Buy
15,164
+412
+3% +$29.8K 0.01% 1169
2020
Q3 		$895K Sell
14,752
-168
-1% -$10.9K ﹤0.01% 1266
2020
Q2 		$984K Buy
14,920
+1,212
+9% +$72.6K 0.01% 1131
2020
Q1 		$647K Buy
13,708
+404
+3% +$20.2K ﹤0.01% 1213
2019
Q4 		$738K Sell
13,304
-276
-2% -$14.5K ﹤0.01% 1273
2019
Q3 		$667K Buy
13,580
+2,376
+21% +$119K ﹤0.01% 1369
2019
Q2 		$582K Buy
11,204
+716
+7% +$36.1K ﹤0.01% 1444
2019
Q1 		$518K Buy
10,488
+2,008
+24% +$90.4K ﹤0.01% 1445
2018
Q4 		$304K Buy
8,480
+1,304
+18% +$54.5K ﹤0.01% 1596
2018
Q3 		$360K Buy
+7,176
New +$318K ﹤0.01% 1635
2017
Q4 		– Sell
-7,020
Closed -$211K – 2376
2017
Q3 		$211K Buy
+7,020
New +$208K ﹤0.01% 1874
2016
Q2 		– Sell
-14,808
Closed -$353K – 2011
2016
Q1 		$353K Buy
14,808
+1,136
+8% +$25K ﹤0.01% 1534
2015
Q4 		$309K Buy
+13,672
New +$312K ﹤0.01% 1553
2015
Q1 		– Sell
-25,508
Closed -$589K – 1689
2014
Q4 		$589K Hold
25,508
– – 0.01% 987
2014
Q3 		$596K Sell
25,508
-2,252
-8% -$52.8K 0.01% 964
2014
Q2 		$642K Buy
27,760
+1,780
+7% +$39.3K 0.01% 971
2014
Q1 		$554K Sell
25,980
-2,280
-8% -$51.3K 0.01% 947
2013
Q4 		$669K Sell
28,260
-44,376
-61% -$962K 0.01% 849
2013
Q3 		$1.46M Buy
72,636
+6,464
+10% +$123K 0.04% 509
2013
Q2 		$1.22M Buy
+66,172
New +$1.1M 0.03% 525

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HighTower Advisors's TECH Position: Q1 2026 in Review

HighTower Advisors sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 5,277 shares — an estimated $310K sold.

HighTower Advisors first reported a position in TECH in Q2 2013 and held it in 40 quarters. The position peaked at $2.39M in Q4 2021. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • HighTower Advisors reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 5,277 Bio-Techne shares in Q1 2026, an estimated $310K.
  • HighTower Advisors first reported a position in Bio-Techne in Q2 2013 and held it in 40 quarters.
  • HighTower Advisors's Bio-Techne position peaked at $2.39M in Q4 2021.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.